FDA NDC Directory · JSON-LD · Markdown
NDC 54766-772 · HUMAN PRESCRIPTION DRUG · GEL
| Generic name | Naftifine Hydrochloride |
|---|---|
| Labeler / Manufacturer | Sebela Pharmaceuticals Inc. |
| Marketing category | New Drug Application (innovator) · App NDA204286 |
| Dosage form / route | GEL · TOPICAL |
| Active ingredients | NAFTIFINE HYDROCHLORIDE (2 g/100g) |
| Marketing started | 20180301 |
| Marketing ended | 20261031 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).